Atlas Trials

TERMINATED

34,140 clinical trials · Status

Sort:Newest firstOldest first

◉ Watch TERMINATED

RecordFirmDate
Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias (NCT05502783)National Heart, Lung, and Blood Institute (NHLBI)2023-03-10
Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline (NCT05980871)National Taiwan University Hospital2023-03-10
A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM (NCT05761301)Alnylam Pharmaceuticals2023-03-10
Chondro-Gide® Bilayer Collagen Membrane in Knee Cartilage Defect Repair (NCT05785949)Geistlich Pharma AG2023-03-10
Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones (NCT05778695)University of Michigan2023-03-09
Adolescent Vaping Characterization and Parent Views on Adolescent Vaping Protocol (NCT05669716)National Institute on Drug Abuse (NIDA)2023-03-09
SGLT2 Inhibitors and Treatment of Heart Failure in Severe Renal Insufficiency (NCT05737186)Peking University People's Hospital2023-03-09
The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder (NCT05711862)The University of Texas Health Science Center, Houston2023-03-09
A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer (NCT05699135)Pfizer2023-03-09
ZYNRELEF for Pain Management in Total Knee Arthroplasty (NCT05644496)Baptist Health South Florida2023-03-09
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants with Advanced Solid Tumors (NCT05781360)Jiangsu Simcere Pharmaceutical Co., Ltd.2023-03-08
A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors (NCT05491317)Genmab2023-03-08
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours (NCT05714553)NuCana plc2023-03-08
WELL-being Improvement Following a SOphrology Intervention in Hospital Staff (NCT05425511)University Hospital, Clermont-Ferrand2023-03-08
Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast Cancer (NCT05583110)Spanish Breast Cancer Research Group2023-03-08
Study of PARPi 2X-121 as Monotherapy and in Combination With Dovitinib in Patients With Advanced Solid Tumors (NCT05571969)Allarity Therapeutics2023-03-08
Tucatinib Together With Pembrolizumab and Trastuzumab (NCT04789096)Breast Cancer Trials, Australia and New Zealand2023-03-07
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid Tumors (NCT04242147)Kadmon, a Sanofi Company2023-03-06
ModPG3 Adult/Ped ISO 81060-2:2018 Study Protocol (NCT05654714)Welch Allyn2023-03-06
Study to Investigate the Long-term Safety of FAB122 in Patients With Amyotrophic Lateral Sclerosis (NCT05866926)Ferrer Internacional S.A.2023-03-06
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer (NCT05065736)Roberto Vargas2023-03-06
Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation (NCT05737706)Mirati Therapeutics Inc.2023-03-06
MENDD Tolerance Assessment Study (NCT06185088)University of Michigan2023-03-06
Event-Related Potential (ERP) Components in Clinical Diagnosis (NCT05673759)Boston University2023-03-06
Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil Levels (NCT05059873)Capital Medical University2023-03-05
Emotional Awareness and Expression Therapy (EAET) for Migraine (NCT05755698)University of Utah2023-03-04
A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 Gene (NCT05469178)BerGenBio ASA2023-03-03
A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery. (NCT05524051)Novartis Pharmaceuticals2023-03-03
SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma. (NCT05293912)Hangzhou Sumgen Biotech Co., Ltd.2023-03-03
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder (NCT05322954)University of Wisconsin, Madison2023-03-03
Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy (NCT05675319)Universitätsklinikum Hamburg-Eppendorf2023-03-03
Brain Stimulation and Visually-guided Navigation (NCT04961645)Emory University2023-03-03
Safety and Performance of Agilik in CP (NCT05746871)IRCCS Eugenio Medea2023-03-02
Phase 2 Clinical Trial of GH001 in Postpartum Depression (NCT05804708)GH Research Ireland Limited2023-03-02
Intra-Osseous Access in Difficult Vascular Access Cases (NCT05708833)Assistance Publique - Hôpitaux de Paris2023-03-02
EO2040 in Combination With Nivolumab, for Treatment of Patients With Minimal Residual Disease of Colorectal Cancer (NCT05350501)Enterome2023-03-01
Deep Brain Stimulation in Treatment Resistant Schizophrenia (NCT02361554)Johns Hopkins University2023-03-01
Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma (NCT06321562)EyeD Pharma2023-03-01
Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase II of the PROmoting Sleep, Patient Engagement and Recovery (PROSPER) Project (NCT05456360)M.D. Anderson Cancer Center2023-03-01
Multimodal Al for Precision Diagnosis of Esophageal Cancer (NCT07629921)Shanghai Zhongshan Hospital2023-03-01
Baby 2 Baby Beneficial Bacteria (NCT05703659)University of Florida2023-03-01
Exercise Program for Maintaining Physical Function and Frailty on Dwelling Older Adults (NCT05726214)University of the Basque Country (UPV/EHU)2023-03-01
BOTOX Effects on Seizure Severity and Susceptibility (NCT05605756)Beth Israel Deaconess Medical Center2023-03-01
Vapocoolant Analgesia for Breast Lymphoscintigraphy (NCT05744557)M.D. Anderson Cancer Center2023-03-01
Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy (NCT04965311)OHSU Knight Cancer Institute2023-03-01
Nutritional Tolerance and Safety of a Tube Feeding Formula (NCT05848583)Société des Produits Nestlé (SPN)2023-03-01
Behavioral Effects of Drugs Inpatient 44 Neurobehavioral Mechanisms of Opioid Choice (NCT06312657)Joshua A. Lile, Ph.D.2023-03-01
Photobiomodulation in the Treatment of Hand-foot Syndrome (NCT05337423)University of Nove de Julho2023-03-01
Training of Arms to Reduce Pain With Peripheral Venous Catheter (NCT05716217)Vejle Hospital2023-02-28
A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms (NCT05787496)NextCure, Inc.2023-02-28
XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) in Treating Melanoma Prior Immune Checkpoint Inhibitor Therapy (NCT05695898)University of California, San Francisco2023-02-28
Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP (NCT05614128)Vanderbilt University Medical Center2023-02-28
A Study of ASP2074 in Adults With Solid Tumors (NCT05646797)Astellas Pharma Global Development, Inc.2023-02-28
A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications (NCT05317078)Amgen2023-02-28
Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA) (NCT05695378)Kainos Medicine Inc.2023-02-27
Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinical Practice (NCT05694013)Hoffmann-La Roche2023-02-27
QPlus Pediatric Reference Interval (NCT05645133)HemoSonics LLC2023-02-27
ZN-c3 in Adult Participants With Metastatic Colorectal Cancer (NCT05743036)K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc2023-02-27
Identification of Human Biomarkers Predictive of Diabetes Remission in Type 2 Diabetes Patient (BARIAKINES) (NCT05472883)University Hospital, Toulouse2023-02-27
Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial) (NCT05049863)Washington University School of Medicine2023-02-27
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors (NCT06094426)Grit Biotechnology2023-02-26
Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia (NCT03066739)University of California, Irvine2023-02-25
A Study to Evaluate Efficacy and Safety of VX-864 in Participants With the PiZZ Genotype (NCT05643495)Vertex Pharmaceuticals Incorporated2023-02-23
A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant (NCT05447663)Novartis Pharmaceuticals2023-02-23
Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive. (NCT05785390)Novatek Pharmaceuticals2023-02-22
W-PPMA for Postpartum Mothers (NCT05662605)Woebot Health2023-02-22
A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer (NCT05673109)Accutar Biotechnology Inc2023-02-22
Survey of Human Rabies Immune Globulin Safety in Children (NCT05382650)The Methodist Hospital Research Institute2023-02-22
Ureteroscopic Laser Modality on Total Lasing Time and Total Energy in Patients With Large, Dense Renal Calculi (NCT05869890)Albany Medical College2023-02-22
Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell Disease (NCT05565092)Alexion Pharmaceuticals, Inc.2023-02-22
A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL) (NCT05403450)Taiho Oncology, Inc.2023-02-22
A Study of JNJ-64281802 for the Prevention of Dengue Infection (NCT05201794)Janssen Research & Development, LLC2023-02-22
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease (NCT05522387)Inmune Bio, Inc.2023-02-21
Pregabalin for Central Sensitization in TKA (NCT05460871)University of Iowa2023-02-21
Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases (NCT05408871)Yale University2023-02-21
Tobacco Treatment Using EMDR (ToTEM) (NCT05594810)IrisZorg2023-02-21
Telerehabilitation of Multidomain Cognitive Impairment in Multiple Sclerosis (NCT05611047)University Hospital, Bordeaux2023-02-21
Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts (NCT05005182)Mayo Clinic2023-02-20
Exercise Preconditioning with Cancer Surgeries (NCT04923672)University of Virginia2023-02-20
The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction (NCT05028101)Case Comprehensive Cancer Center2023-02-20
ALgorithms Adapted From Remote Monitoring (NCT05782140)Mayo Clinic2023-02-20
A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014) (NCT05810961)argenx2023-02-20
A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia. (NCT05752123)EdiGene (GuangZhou) Inc.2023-02-18
Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT05498220)UNC Lineberger Comprehensive Cancer Center2023-02-17
Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer (NCT05617313)Jeffrey Clarke2023-02-17
PROMs and Patellar Tracking After MPFL Reconstruction With or Without Tibial Tuberosity Transposition (NCT05547269)Radboud University Medical Center2023-02-17
CD8 Minibody Repeatability Study (NCT05744128)ImaginAb, Inc.2023-02-16
Stress and Anxiety Effects on Overactive Bladder (NCT05087810)Vanderbilt University Medical Center2023-02-16
Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD) (NCT05605548)Virginia Commonwealth University2023-02-16
Siltuximab in Large Granular Lymphocytic Leukemia (LGLL) (NCT05316116)H. Lee Moffitt Cancer Center and Research Institute2023-02-15
A Phase I Study of RGT-264 in Subjects With Advanced Solid Tumors (NCT05764915)Regor Pharmaceuticals Inc.2023-02-15
Topical Palm Tocotrienols on Blemish-prone Skin (NCT05756881)Universiti Sains Malaysia2023-02-15
NMES for Achilles Tendon Rupture (NCT04727047)Penn State University2023-02-15
Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation (NCT05523440)University of Oklahoma2023-02-15
A Pragmatic Approach to CKD Patient Education (NCT05138419)University of Arkansas2023-02-13
Pippa Pessary Study (Clinical Trial) (NCT05611970)Liv Labs Inc.2023-02-13
A Study of Remote Electrical Neuromodulation for Acute Procedural Pain (NCT05730556)Mayo Clinic2023-02-13
A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL (NCT05515406)Ono Pharmaceutical Co., Ltd.2023-02-13
A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients (NCT05679388)University of Chicago2023-02-13
Beta-glucan and Fatigue in HSCT Survivors (NCT05524688)University of Florida2023-02-10
← Previous Next →

Track TERMINATED automatically

Every clearance here is in the API, with alerts when new ones post.